A patented unique strain of Lactococcus lactis (LC-Plasma)
Type: Postbiotics
Application: Supplement & Nutrition
Comprehensive Immune Activation
IMMUSE™ is a novel postbiotic which is a patented strain of Lactococcus lactis that provides clinically researched immune support*. A strong immune system is crucial to maintaining good health. Today’s consumers face a constant onslaught on their immune systems from the stresses of modern life, work, diet and other lifestyle factors. With a unique mechanism of action that activates pDC (plasmacytoid dendritic cells), IMMUSE™ is a novel solution for your next immunity product.
IMMUSE™ Earns Frost & Sullivan 2021 New Product Innovation Award
Add IMMUSE™ to your next product
Contact us for product information
Related News
Kyowa Hakko Announces Glaxon’s Limited-Time Offer Becomes A Permanent Feature
October 26, 2022New York, NYAfter a resoundingly successful limited-time offering, Glaxon™ has now added Kyowa Hakko’s IMMUSE™ to all SuperGreens Immune formulas. Glaxon™, producer of sports nutrition dietary supplements, launched this summer a SuperGreens Enhanced Immune Edition that, in addition to the power of Glaxon™'s trademarked Supershrooms® Organic Mushroom Blend, included IMMUSE™, a postbiotic that provides immune support at a cellular level - both of which support the immune systems of its customers. Read more »
Kyowa Hakko USA Announces the Appointment of Dr. Colin Hill to the Scientific Advisory Board of Award-Winning Postbiotic IMMUSE™
May 19, 2022NEW YORK (PRWEB)With an impressive background in mining the microbiome for novel therapies, Prof. Hill helped with the definition of a postbiotic as a part of ISAPP. Read more »
Copyright © 1998 – 2022 by KYOWA HAKKO U.S.A., INC. All Rights Reserved. | AWS
* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.